Fernand Labrie
Publications
Page 15 of 26, showing 50 records out of 1263 total, starting on record 701, ending on 750
| Publication | Category | Year |
|---|---|---|
| 4118. Candas, B., Lacoste, D., Normand, M., Labrie, F. (1988) Model of the distribution and metabolism of the Gonatropin-releasing hormone (GnRH) Agonist (D-Trp6,Des-Gly-Nh210)GnRH ethylamide in man. J. Clinical Endocrinol and Metabol, 70: 1046-54. | All publications | 1988 |
| 4119. Crim, L.W., St-Arnaud, R., Lavoie, M., Labrie, F (1988) A study of LHRH receptors in the pituitary gland of the winter flounder (Pseudopleuronectes americanus Walbum). Gen. Compar. Endocrinol., 69: 372-377. | All publications | 1988 |
| 1070. Cusan, L., Dupont, A., Tremblay, R., Labrie, F. (1988) Treatment of hirsutism with the pure antiandrogen flutamide, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent research on gynecological endocrinology: Selected free communications presented at the 1st Congress of the International Society of Gynecological Endocrinology, Crans-Montana, Switzerland, March 1988, pp 577-582. | All publications | 1988 |
| 513. Dauvois, S., Labrie, F. (1988) Androstenedione (4-dione) is a potent stimulus for the growth of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat, in: 1st Congress of the International Society of Gynecological Endocrinology, Crans-Montana, Switzerland, pp 626-630. | All publications | 1988 |
| 202. Dubé, D., Pelletier, G., Labrie, F. (1988) The luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6-des-Gly-NH2(10)]-LHRH ethylamide has no direct effect on spermatogenesis in the rat. Biol. Reprod., 38: 1165-1170. | All publications | 1988 |
| 204. Dupont, A., Labrie, F., Giguère, M., Borsanyi, J.-P., Lacourcière, Y., Bélanger, A., Lachance, R., Emond, J., Monfette, G. (1988) Combination therapy with Flutamide and castration (orchiectomy or LHRH agonist) in untreated patients with advanced prostate cancer, in: Höffken, K., ed. LHRH agonists in Oncology. Symposium on GnRH Analogues, Essen, pp 60-71. | All publications | 1988 |
| 203. Dupont, A., Labrie, F., Giguere, M., Borsanyi, J.-P., Lacourcière, Y., Bergeron, N., Cusan, L., Bélanger, A., Emond, J. (1988) Combination therapy with Flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinoma. Eur. J. Cancer Oncol., 24: 659-666. | All publications | 1988 |
| 4125. Govindan, M., Burelle, M., Cantin, C., Devic, M., Labrie, C., Labrie, F., Lachance, Y., Leblanc, G., Lefebvre, C., Patel, P., Simard, J., Stropp, U. (1988) Isolation and sequence of the human glucocorticoid receptor gene promoter, in: Moudgil, E., ed. Steroid Receptors in Health and Disease, New York, Plenum Press, pp 187-206. | All publications | 1988 |
| 4126. Govindan, M.V., Burelle, M., Cantin, C., Labrie, C., Labrie, F., Lachance, Y., Leblanc, G., Lefebvre, C., Patel, P., Simard, J. (1988) Cloning of the human androgen receptor cDNA, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Proceeding of the 3rd International Congress on Hormones and Cancer, New York, Raven Press, pp 49-54. | All publications | 1988 |
| 4127. Hubert, J.F., Simard, J., Gagné, B., Barden, N., Labrie, F. (1988) Effect of luteinizing hormone-releasing hormone (LHRH) and [D-Trp6 des-Gly-NH210]LHRH ethylamide on a-subunit and LH? messenger ribonucleic acid levels in rat anterior pituitary cells in culture. Mol. Endocrinol., 2: 521-527. | All publications | 1988 |
| 1071. Hubert, J.F., Thibault, L., Turcotte, R., Labrie, F. (1988) Androgens exert selective effects on protein kinase C-induced LH and FSH release in rat anterior pituitary cells in culture. Neuroendocrinology, 48: 360-366. | All publications | 1988 |
| 205. Labrie, C., Bélanger, A., Labrie, F. (1988) Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology, 123: 1412-1417. | All publications | 1988 |
| 206. Labrie, F., Bélanger, A., Veilleux, R., Lacoste, D., Labrie, C., Marchetti, B., Poulin, R., Dupont, A., Cusan, L., Luthy, I. (1988) Rationale for maximal androgen withdrawal in the therapy of prostate cancer, in: Furr, M. et Denis, L., eds: Baillieres Clinics in Oncology on Prostate Cancer, London, Saunders Company, pp 597-619. | All publications | 1988 |
| 207. Labrie, F., Dupont, A., Bélanger, A., Simard, J., Labrie, C., Poulin, R., Luthy, I., Veilleux, R., Lacoste, D., Marchetti, B., Cusan, L., Manhès, G., Monfette, G., Emond, J. (1988) Combination therapy with the antiandrogen Flutamide and the LHRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide in prostate cancer: rationale and 5-year clinical experience, in: Chretien, M. et McKerns, K.W., eds: Molecular Biology of Brain and Endocrine Peptidergic Systems, New York, Plenum Press, pp 83-101. | All publications | 1988 |
| 208. Labrie, F., Dupont, A., Cusan, L., Bélanger, A., Giguère, M., Labrie, C., Lacourcière, Y., Monfette, G., Emond, J. (1988) Combination therapy with Flutamide and [D-Trp6, des-Gly-NH210]LHRH ethylamide in stage C and D prostate cancer: Today's therapy of choice - Rationale and 5-year clinical experience. Prog. Clin. Biol. Res., 262: 11-63. | All publications | 1988 |
| 209. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Borsanyi, J.P., Lacourcière, Y., Bélanger, A., Emond, J., Monfette, G., Boucher, H., Lachance, R. (1988) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice. J. Steroid Biochem., 30: 107-117. | All publications | 1988 |
| 210. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Lacourcière, Y., Bélanger, A., Monfette, G., Emond, J. (1988) Combination therapy with Flutamide and [D-Trp6]LHRH ethylamide in advanced (stages C and D) previously untreated prostate cancer, in: Motta, M. et Serio, M., eds: Hormonal therapy of prostatic diseases: basic and clinical aspects: International Symposium, Milano, Italy, April 6-8 1987: abstracts of lectures and free communications, pp 312-333. | All publications | 1988 |
| 211. Labrie, F., Dupont, A., Giguère, M., Borsanyi, J.P., Lacourcière, Y., Bélanger, A., Lachance, R., Emond, J., Monfette, G. (1988) Combination therapy with Flutamide and castration (orchiectomy of LHRH agonists): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer. Review Article. Prog. Clin. Biol. Res., 260: 41-62. | All publications | 1988 |
| 212. Labrie, F., Dupont, A., Giguère, M., Borsanyi, J.P., Lacourcière, Y., Monfette, G., Emond, J., Bergeron, N. (1988) Benefits of combination therapy with Flutamide in patients relapsing after castration. Br. J. Urol., 61: 341-346. | All publications | 1988 |
| 213. Labrie, F., Dupont, A., Giguère, M., Cusan, L., Bergeron, N., Emond, J., Monfette, G., Lacourcière, Y., Boucher, H., Lachance, R. (1988) Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma. Eur. J. Cancer Clin. Oncol., 24: 1869-1878. | All publications | 1988 |
| 514. Labrie, F., Veilleux, R., Fournier, A. (1988) Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in culture. Mol. Cell. Endocrinol., 58: 207-211. | All publications | 1988 |
| 214. Labrie, F., Veilleux, R., Fournier, A. (1988) Low androgen levels induce the development of androgen hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 1138-1147. | All publications | 1988 |
| 215. Labrie, F., Veilleux, R., Fournier, A. (1988) Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 966-970. | All publications | 1988 |
| 216. Lacoste, D., St-Arnaud, R., Bélanger, A., Labrie, F. (1988) A pure antiandrogen does not interfere with the LHRH agonist-induced blockade of testicular androgen secretion in the dog. Mol. Cell. Endocrinol., 56: 141-147. | All publications | 1988 |
| 217. Lacoste, D., St-Arnaud, R., Caron, S., Bélanger, A., Labrie, F. (1988) The rise in testicular androgens during the first days of treatment with an LHRH agonist in the dog can be blocked by aminoglutethimide or ketoconazole. J. Steroid Biochem., 31: 963-970. | All publications | 1988 |
| 218. Luthy, I., Bégin, D., Labrie, F. (1988) Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17?-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture. Endocrinology, 123: 1418-1424. | All publications | 1988 |
| 219. Luthy, I.A., Bégin, D.J., Labrie, F. (1988) Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J. Steroid Biochem., 31: 845-852. | All publications | 1988 |
| 220. Marchetti, B., Labrie, F. (1988) Characteristics of Flutamide action on prostatic and testicular functions in the rat. J. Steroid Biochem., 29: 691-698. | All publications | 1988 |
| 221. Marchetti, B., Poulin, R., Plante, M., Labrie, F. (1988) Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate. J. Steroid Biochem., 31: 411-419. | All publications | 1988 |
| 222. Moorjani, S., Dupont, A., Labrie, F., Lupien, P.J., Gagné, C., Brun, D., Giguère, M., Bélanger, A., Cusan, L. (1988) Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen and combination treatment with LHRH agonist and Flutamide. J. Clin. Endocrinol. Metab., 66: 314-322. | All publications | 1988 |
| 223. Pelletier, G., Labrie, C., Simard, J., Duval, M., Martinoli, M.G., Zhao, H., Labrie, F. (1988) Effects of sex steroids on regulation of the levels of C1 peptide of rat prostatic steroid-binding protein mRNA evaluated by in situ hybridization. J. Mol. Endocrinol., 1: 213-223. | All publications | 1988 |
| 224. Plante, M., Lapointe, S., Labrie, F. (1988) Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. J. Steroid Biochem., 31: 61-64. | All publications | 1988 |
| 520. Poirier, D., Poulin, R., Labrie, F. (1988) Screening of lipoidal steroid formation in the ZR-75-1 human breast cancer cell line, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Progress in Cancer Research and Therapy. Hormones and Cancer, New York, Raven Press, pp 384-387. | All publications | 1988 |
| 521. Poulin, R., Baker, D., Labrie, F. (1988) Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213-225. | All publications | 1988 |
| 522. Poulin, R., Mérand, Y., Labrie, F. (1988) Antiestrogenic properties of a 7?-alkylated derivative of 17?-estradiol in ZR-75-1 human breast cancer, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent Research in Gynecological Endocrinology, Parthenon Publishing Group, pp 631-634. | All publications | 1988 |
| 226. Rousseau, L., Dupont, A., Labrie, F., Couture, M. (1988) Sexuality and antihormonal therapy in prostate cancer, in: Eicher, W. et Kockott, G., eds: Sexology, Berlin, Springer-Verlag, pp 290-303. | All publications | 1988 |
| 225. Rousseau, L., Dupont, A., Labrie, F., Couture, M. (1988) Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen Flutamide with medical (LHRH agonist) or surgical castration. Arch. Sex. Behav., 17: 87-98. | All publications | 1988 |
| 227. Simard, J., Labrie, C., Hubert, J.-F., Labrie, F. (1988) Modulation by sex steroids and [D-Trp6, des-Gly-NH210]LHRH ethylamide of a subunit and LH? mRNA levels in the rat anterior pituitary gland. Mol. Endocrinol., 2: 775-784. | All publications | 1988 |
| 653. Simard, J., Vincent, A., Duchesne, R., Labrie, F. (1988) Full estrogenic activity of C19-?5 adrenal steroids in rat pituitary lactotrophs and somatotrophs. Mol. Cell. Endocrinol., 55: 233-242. | All publications | 1988 |
| 523. Spinola, P.G., Marchetti, B., Mérand, Y., Labrie, F. (1988) Effects of the aromatase inhibitor 4-hydroxyandrostenedione and antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res. Treat., 12: 287-296. | All publications | 1988 |
| 228. St-Arnaud, R., Poyet, P., Walker, P., Labrie, F. (1988) Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol. Cell. Endocrinol., 56: 21-27. | All publications | 1988 |
| 229. Brochu, M., Bélanger, A., Dupont, A., Cusan, L., Labrie, F. (1987) Effects of Flutamide and aminoglutethimide on plasma 5?-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. J. Steroid Biochem., 28: 619-622. | All publications | 1987 |
| 230. Dubé, D., Assaf, A., Pelletier, G., Labrie, F. (1987) Morphological study of the effects of an GnRH agonist on the canine testis after 4 months of treatment and recovery. Acta Endocrinol. (Copenh.), 116: 413-417. | All publications | 1987 |
| 231. Dubé, D., Pelletier, G., Labrie, F. (1987) Morphological studies of the canine pituitary LH cells after long-term treatment with the LHRH agonist [D-Trp6]LHRH ethylamide. Endocrinology, 120: 589-594. | All publications | 1987 |
| 4162. Harnois, C., Labrie, F., Dupont, A., Malenfant, M. (1987) Ocular toxicity of Anandron. Br. J. Ophthalmol., 71: 639-640. | All publications | 1987 |
| 4163. Labrie, C., Cusan, L., Plante, M., Lapointe, S., Labrie, F. (1987) Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer. J. Steroid Biochem., 28: 379-384. | All publications | 1987 |
| 233. Labrie, F. (1987) Tratamiento del cancer de prostata mediante bloqueo hormonal completo, in: Carcinoma de Prostata: Avances en el Tratamiento Hormonal Patrocinado por la Asociacion Espanola de Urologia Barcelona, pp 61-67. | All publications | 1987 |
| 234. Labrie, F., Dupont, A., Bélanger, A. (1987) LHRH agonists and antiandrogens in prostate cancer, in: Catalona, W.J. et Ratliff, T.L., eds: Genitourinary Cancer, Boston, Martinus Nijhoff Publishing, pp 157-200. | All publications | 1987 |
| 235. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Giguère, M., Lacourcière, Y., Luthy, I., Bégin, D., Labrie, C., Simard, J., Monfette, G., Emond, J. (1987) Combination therapy in stage C and D prostatic cancer: rationale and 5-year clinical experience, in: Poste, G. et Fidler, I.J., eds: Cancer and Metastatic Reviews, Boston, Martinus Nijhoff Publishing, pp 615-636. | All publications | 1987 |
| 236. Labrie, F., Dupont, A., Bélanger, A., Emond, J., Monfette, G., Luthy, I., Simard, J., Lachance, R. (1987) Flutamide in combination with castration (surgical or medical) is the standard treatment in advanced prostate cancer. J. Drug Develop., 1: 34-51. | All publications | 1987 |